Immune marker profiling and PD-L1, PD-L2 expression mechanisms across non-small cell lung cancer mutations.

9076Background: PD-1/PD-L1 axis inhibitors have been proven effective, especially in patients expressing Programmed Death Ligand 1 (PD-L1). Their clinical efficacy in patients with epidermal growth...